3-Benzyl-7-chloro-3H-[1,2,3]triazolo[4,5-d]pyrimidine

Catalog No. :
ACTMDV501
CAS No. :
21410-06-0
Molecular Formula :
C11H8ClN5
Molecular Weight :
245.67

IUPAC Name:3-benzyl-7-chloro-3H-[1,2,3]triazolo[4,5-d]pyrimidine

3-Benzyl-7-chloro-3H-[1,2,3]triazolo[4,5-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$71.00Login to see priceInquiryInquiry
1g95%$137.00Login to see priceInquiryInquiry
5g95%$391.00Login to see priceInquiryInquiry
10g95%$581.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Benzyl-7-chloro-3H-[1,2,3]triazolo[4,5-d]pyrimidine
IUPAC Name3-benzyl-7-chloro-3H-[1,2,3]triazolo[4,5-d]pyrimidine
MDL No.MFCD09038669
Molecular FormulaC11H8ClN5
Molecular Weight245.67
SMILESC(C1=CC=CC=C1)[N]2C3=C(N=N2)C(=NC=N3)Cl
InChI KeyKVYUVZPCMWVWAU-UHFFFAOYSA-N
Synonym3-BENZYL-7-CHLORO-3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE;3H-1,2,3-Triazolo[4,5-d]pyrimidine, 7-chloro-3-(phenylmethyl)-;3-benzyl-7-chlorotriazolo[4,5-d]pyrimidine;3-benzyl-7-chloro-3h - [1,2,3] thiazol [4,5-d] pyrimidine
CAS No.21410-06-0
PubChem CID12597307

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTMDV501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMDV501 route product structure diagram
    ACTMDV50121410-06-0
Inquiry

2. ACTMDV501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMDV501 route product structure diagram
    ACTMDV50121410-06-0
Inquiry

Comments (0)